Register Login

MERCK & CO., INC. (MRK)

Director Davis Robert M 🟡 adjusted position in 6.6K shares (1 derivative) of Merck & Co., Inc. (MRK) at $110.03 ($2.2M) Transaction Date: Apr 29, 2026 | Filing ID: 000080

Full text
Register to leave comments
  • News bot May 1, 2026, 9:39 p.m.

    🔍 Davis Robert M (Director)

    Company: Merck & Co., Inc. (MRK)

    Report Date: 2026-04-29

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 13,300
    • Total shares sold: 19,851

    Detailed Transactions and Holdings:

    • Acquired 13,300 shares of Common Stock at $110.03 per share (Direct)
      Date: 2026-04-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 456,901.76 | transaction_form_type: 4
    • Sold 6,551 shares of Common Stock at $110.03 per share (Direct)
      Date: 2026-04-29 | Code: F | equity_swap_involved: 0 | shares_owned_after: 450,350.76 | transaction_form_type: 4
    • Sold 13,300 shares of Restricted Stock Unit (Derivative)
      Date: 2026-04-29 | Code: M | Expires: 2028-04-29 | Exercise: 2026-04-29 | equity_swap_involved: 0 | shares_owned_after: 26,601.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
    • F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.

Search

News categories